About this Class

Register The NCI’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) is a national effort to accelerate the understanding of the molecular basis of cancer through the application of large-scale proteogenomics. The next TEAG forum will focus on NCI resources generated through the CPTAC pipeline that are available for conducting proteomic research. CPTAC Tumor Characterization Program and Data Resources Ana I. Robles, Ph.D. Office of Cancer Clinical Proteomics Research (OCCPR) National Cancer Institute CPTAC Pipeline Components and the Assay Portal Mehdi Mesri, M.Med.Sci., Ph.D. OCCPR National Cancer Institute Proteomic Pipeline Support and NCI Collaborations Tara Hiltke, Ph.D. OCCPR National Cancer Institute